Your browser doesn't support javascript.
loading
MYB orchestrates T cell exhaustion and response to checkpoint inhibition.
Tsui, Carlson; Kretschmer, Lorenz; Rapelius, Svenja; Gabriel, Sarah S; Chisanga, David; Knöpper, Konrad; Utzschneider, Daniel T; Nüssing, Simone; Liao, Yang; Mason, Teisha; Torres, Santiago Valle; Wilcox, Stephen A; Kanev, Krystian; Jarosch, Sebastian; Leube, Justin; Nutt, Stephen L; Zehn, Dietmar; Parish, Ian A; Kastenmüller, Wolfgang; Shi, Wei; Buchholz, Veit R; Kallies, Axel.
Afiliação
  • Tsui C; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
  • Kretschmer L; Institute for Medical Microbiology, Immunology and Hygiene, School of Medicine, Technical University of Munich (TUM), Munich, Germany.
  • Rapelius S; Institute for Medical Microbiology, Immunology and Hygiene, School of Medicine, Technical University of Munich (TUM), Munich, Germany.
  • Gabriel SS; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
  • Chisanga D; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.
  • Knöpper K; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Utzschneider DT; Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia.
  • Nüssing S; School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia.
  • Liao Y; Würzburg Institute of Systems Immunology, Max Planck Research Group, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.
  • Mason T; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
  • Torres SV; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Wilcox SA; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
  • Kanev K; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.
  • Jarosch S; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Leube J; Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia.
  • Nutt SL; School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia.
  • Zehn D; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
  • Parish IA; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
  • Kastenmüller W; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Shi W; Division of Animal Physiology and Immunology, School of Life Sciences Weihenstephan, Technical University of Munich (TUM), Freising, Germany.
  • Buchholz VR; Institute for Medical Microbiology, Immunology and Hygiene, School of Medicine, Technical University of Munich (TUM), Munich, Germany.
  • Kallies A; Institute for Medical Microbiology, Immunology and Hygiene, School of Medicine, Technical University of Munich (TUM), Munich, Germany.
Nature ; 609(7926): 354-360, 2022 09.
Article em En | MEDLINE | ID: mdl-35978192
ABSTRACT
CD8+ T cells that respond to chronic viral infections or cancer are characterized by the expression of inhibitory receptors such as programmed cell death protein 1 (PD-1) and by the impaired production of cytokines. This state of restrained functionality-which is referred to as T cell exhaustion1,2-is maintained by precursors of exhausted T (TPEX) cells that express the transcription factor T cell factor 1 (TCF1), self-renew and give rise to TCF1- exhausted effector T cells3-6. Here we show that the long-term proliferative potential, multipotency and repopulation capacity of exhausted T cells during chronic infection are selectively preserved in a small population of transcriptionally distinct CD62L+ TPEX cells. The transcription factor MYB is not only essential for the development of CD62L+ TPEX cells and maintenance of the antiviral CD8+ T cell response, but also induces functional exhaustion and thereby prevents lethal immunopathology. Furthermore, the proliferative burst in response to PD-1 checkpoint inhibition originates exclusively from CD62L+ TPEX cells and depends on MYB. Our findings identify CD62L+ TPEX cells as a stem-like population that is central to the maintenance of long-term antiviral immunity and responsiveness to immunotherapy. Moreover, they show that MYB is a transcriptional orchestrator of two fundamental aspects of exhausted T cell responses the downregulation of effector function and the long-term preservation of self-renewal capacity.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Proteínas Proto-Oncogênicas c-myb / Receptor de Morte Celular Programada 1 Idioma: En Revista: Nature Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Proteínas Proto-Oncogênicas c-myb / Receptor de Morte Celular Programada 1 Idioma: En Revista: Nature Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália